The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Bladder cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Rosenberg, J. E., Hoffman-Censits, J., Powles, T., van der Heijden, M. S., Balar, A. V., Necchi, A., Dawson, N., O'Donnell, P. H., Balmanoukian, A., Loriot, Y., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00561-4 · Cited by 3,669
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S., Feng, A.-C., Boyd, S., Skinner, E., Bochner, B., Thangathurai, D., Mikhail, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.666 · Cited by 3,530
Sylvester, R. J., van der Meijden, A. P. M., Oosterlinck, W., Witjes, J. A., Bouffioux, C., Denis, L., Newling, D. W. W., & Kurth, K. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.031 · Cited by 3,013
Comprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,990
The Global Burden of Cancer 2013
Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., Allen, C., Hansen, G., Woodbrook, R., Wolfe, C., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0735 · Cited by 2,707
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017) · European Urology · doi:10.1016/j.eururo.2016.06.010 · Cited by 2,514
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Babjuk, M., Böhle, A., Burger, M., Capoun, O., Cohen, D., Compérat, E. M., Hernández, V., Kaasinen, E., Palou, J., Rouprêt, M., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.05.041 · Cited by 2,241
Self-citationEpidemiology and Risk Factors of Urothelial Bladder Cancer
Burger, M., Catto, J. W. F., Dalbagni, G., Grossman, H. B., Herr, H., Karakiewicz, P., Kassouf, W., Kiemeney, L. A., La Vecchia, C., Shariat, S., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.07.033 · Cited by 2,164
Self-citationChoi, W., Porten, S., Kim, S., Willis, D., Plimack, E. R., Hoffman-Censits, J., Roth, B., Cheng, T., Tran, M., Lee, I.-L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.009 · Cited by 1,716
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., Wollum, A., Sanman, E., Wulf, S., Lopez, A. D., et al. (2014) · JAMA · doi:10.1001/jama.2013.284692 · Cited by 1,576
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
Alfred Witjes, J., Lebret, T., Compérat, E. M., Cowan, N. C., De Santis, M., Bruins, H. M., Hernández, V., Espinós, E. L., Dunn, J., Rouanne, M., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.06.020 · Cited by 1,476
Kamat, A. M., Hahn, N. M., Efstathiou, J. A., Lerner, S. P., Malmström, P.-U., Choi, W., Guo, C. C., Lotan, Y., & Kassouf, W. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30512-8 · Cited by 1,421
Self-citationVelikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.078 · Cited by 1,382
Vale, C. L. (2005) · European Urology · doi:10.1016/j.eururo.2005.04.006 · Cited by 1,325
SYLVESTER, R. J., van der MEIJDEN, A. P. M., & LAMM, D. L. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64273-5 · Cited by 1,312
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Knowles, M. A., & Hurst, C. D. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3817 · Cited by 1,247
Self-citationAssociation Between Smoking and Risk of Bladder Cancer Among Men and Women
Freedman, N. D. (2011) · JAMA · doi:10.1001/jama.2011.1142 · Cited by 1,141
Detmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002) · JAMA · doi:10.1001/jama.288.23.3027 · Cited by 1,011
A Molecular Taxonomy for Urothelial Carcinoma
Sjödahl, G., Lauss, M., Lövgren, K., Chebil, G., Gudjonsson, S., Veerla, S., Patschan, O., Aine, M., Fernö, M., Ringnér, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0077-t · Cited by 944
The present and future burden of urinary bladder cancer in the world
Ploeg, M., Aben, K. K. H., & Kiemeney, L. A. (2009) · World Journal of Urology · doi:10.1007/s00345-009-0383-3 · Cited by 927
Snyder, C. F., Aaronson, N. K., Choucair, A. K., Elliott, T. E., Greenhalgh, J., Halyard, M. Y., Hess, R., Miller, D. M., Reeve, B. B., & Santana, M. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0054-x · Cited by 910
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Damrauer, J. S., Hoadley, K. A., Chism, D. D., Fan, C., Tiganelli, C. J., Wobker, S. E., Yeh, J. J., Milowsky, M. I., Iyer, G., Parker, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318376111 · Cited by 877
Oncolytic virus therapy: A new era of cancer treatment at dawn
Fukuhara, H., Ino, Y., & Todo, T. (2016) · Cancer Science · doi:10.1111/cas.13027 · Cited by 774
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
SYLVESTER, R. J., OOSTERLINCK, W., & van der MEIJDEN, A. P. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000125486.92260.b2 · Cited by 743
Cerantola, Y., Valerio, M., Persson, B., Jichlinski, P., Ljungqvist, O., Hubner, M., Kassouf, W., Muller, S., Baldini, G., Carli, F., et al. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.09.014 · Cited by 712
Genome Sequencing Identifies a Basis for Everolimus Sensitivity
Iyer, G., Hanrahan, A. J., Milowsky, M. I., Al-Ahmadie, H., Scott, S. N., Janakiraman, M., Pirun, M., Sander, C., Socci, N. D., Ostrovnaya, I., et al. (2012) · Science · doi:10.1126/science.1226344 · Cited by 690
Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck, C., Ohneseit, P. F., Gonzalez‐Zulueta, M., Esrig, D., Miyao, N., Tsai, Y., Lerner, S. P., Schmütte, C., Yang, A. S., & Cote, R. (1994) · PubMed · Cited by 680
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
Dobruch, J., Daneshmand, S., Fisch, M., Lotan, Y., Noon, A. P., Resnick, M. J., Shariat, S. F., Zlotta, A. R., & Boorjian, S. A. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.037 · Cited by 673
Self-citationChan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., Gill, H., Presti, J., Chang, H. Y., van de Rijn, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906549106 · Cited by 660
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Hedegaard, J., Lamy, P., Nordentoft, I., Algaba, F., Høyer, S., Ulhøi, B. P., Vang, S., Reinert, T., Hermann, G. G., Mogensen, K., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.004 · Cited by 639
Self-citationSomatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
Van Allen, E. M., Mouw, K. W., Kim, P., Iyer, G., Wagle, N., Al-Ahmadie, H., Zhu, C., Ostrovnaya, I., Kryukov, G. V., O'Connor, K. W., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0623 · Cited by 620
BÖHLE, A., JOCHAM, D., & BOCK, P. R. (2003) · Journal of Urology · doi:10.1016/s0022-5347(05)64043-8 · Cited by 616
Bochner, B. H., Dalbagni, G., Sjoberg, D. D., Silberstein, J., Keren Paz, G. E., Donat, S. M., Coleman, J. A., Mathew, S., Vickers, A., Schnorr, G. C., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.11.043 · Cited by 604
Clonal Origin of Bladder Cancer
Sidransky, D., Frost, P., Von Eschenbach, A., Oyasu, R., Preisinger, A. C., & Vogelstein, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203123261104 · Cited by 532
Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors
Billerey, C., Chopin, D., Aubriot-Lorton, M.-H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., Bralet, M.-P., Lefrere-Belda, M.-A., Lahaye, J.-B., Abbou, C. C., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64665-2 · Cited by 498
Guo, G., Sun, X., Chen, C., Wu, S., Huang, P., Li, Z., Dean, M., Huang, Y., Jia, W., Zhou, Q., et al. (2013) · Nature Genetics · doi:10.1038/ng.2798 · Cited by 482
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
Davis, R., Jones, J. S., Barocas, D. A., Castle, E. P., Lang, E. K., Leveillee, R. J., Messing, E. M., Miller, S. D., Peterson, A. C., Turk, T. M. T., et al. (2012) · Journal of Urology · doi:10.1016/j.juro.2012.09.078 · Cited by 482
Rothman, N., Garcia-Closas, M., Chatterjee, N., Malats, N., Wu, X., Figueroa, J. D., Real, F. X., Van Den Berg, D., Matullo, G., Baris, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.687 · Cited by 481
Self-citationGene Expression in the Urinary Bladder
Dyrskjøt, L., Kruhøffer, M., Thykjaer, T., Marcussen, N., Jensen, J. L., Møller, K., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3620 · Cited by 451
Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder
Shin, K., Lee, J., Guo, N., Kim, J., Lim, A., Qu, L., Mysorekar, I. U., & Beachy, P. A. (2011) · Nature · doi:10.1038/nature09851 · Cited by 443
Novara, G., Catto, J. W. F., Wilson, T., Annerstedt, M., Chan, K., Murphy, D. G., Motttrie, A., Peabody, J. O., Skinner, E. C., Wiklund, P. N., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.12.007 · Cited by 443
Sylvester, R. J., Brausi, M. A., Kirkels, W. J., Hoeltl, W., Calais Da Silva, F., Powell, P. H., Prescott, S., Kirkali, Z., van de Beek, C., Gorlia, T., et al. (2010) · European Urology · doi:10.1016/j.eururo.2009.12.024 · Cited by 441
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Kim, J., Mouw, K. W., Polak, P., Braunstein, L. Z., Kamburov, A., Tiao, G., Kwiatkowski, D. J., Rosenberg, J. E., Van Allen, E. M., D'Andrea, A. D., et al. (2016) · Nature Genetics · doi:10.1038/ng.3557 · Cited by 413
Leow, J. J., Martin-Doyle, W., Rajagopal, P. S., Patel, C. G., Anderson, E. M., Rothman, A. T., Cote, R. J., Urun, Y., Chang, S. L., Choueiri, T. K., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.033 · Cited by 411
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
Kiemeney, L. A., Thorlacius, S., Sulem, P., Geller, F., Aben, K. K. H., Stacey, S. N., Gudmundsson, J., Jakobsdottir, M., Bergthorsson, J. T., Sigurdsson, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.229 · Cited by 410
Self-citationOncogenic FGFR3 gene fusions in bladder cancer
Williams, S. V., Hurst, C. D., & Knowles, M. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds486 · Cited by 390
Self-citationSternberg, C. N., Skoneczna, I., Kerst, J. M., Albers, P., Fossa, S. D., Agerbaek, M., Dumez, H., de Santis, M., Théodore, C., Leahy, M. G., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71160-x · Cited by 389
Rebouissou, S., Bernard-Pierrot, I., de Reyniès, A., Lepage, M.-L., Krucker, C., Chapeaublanc, E., Hérault, A., Kamoun, A., Caillault, A., Letouzé, E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008970 · Cited by 386
Tomlinson, D., Baldo, O., Harnden, P., & Knowles, M. (2007) · The Journal of Pathology · doi:10.1002/path.2207 · Cited by 363
Self-citationThe global burden of urinary bladder cancer
Parkin, D. M. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/03008880802285032 · Cited by 357
Ploussard, G., Daneshmand, S., Efstathiou, J. A., Herr, H. W., James, N. D., Rödel, C. M., Shariat, S. F., Shipley, W. U., Sternberg, C. N., Thalmann, G. N., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.02.038 · Cited by 355
Yafi, F. A., Brimo, F., Steinberg, J., Aprikian, A. G., Tanguay, S., & Kassouf, W. (2015) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.06.008 · Cited by 346
Dadhania, V., Zhang, M., Zhang, L., Bondaruk, J., Majewski, T., Siefker-Radtke, A., Guo, C. C., Dinney, C., Cogdell, D. E., Zhang, S., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.036 · Cited by 345
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
Jebar, A. H., Hurst, C. D., Tomlinson, D. C., Johnston, C., Taylor, C. F., & Knowles, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208705 · Cited by 340
Self-citationEnhanced recovery after surgery (ERAS) protocols: Time to change practice?
Melnyk, M., Casey, R. G., Black, P., & Koupparis, A. J. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.693 · Cited by 332
Inactivation of p53 and Pten promotes invasive bladder cancer
Puzio-Kuter, A. M., Castillo-Martin, M., Kinkade, C. W., Wang, X., Shen, T. H., Matos, T., Shen, M. M., Cordon-Cardo, C., & Abate-Shen, C. (2009) · Genes & Development · doi:10.1101/gad.1772909 · Cited by 329
Lindgren, D., Frigyesi, A., Gudjonsson, S., Sjödahl, G., Hallden, C., Chebil, G., Veerla, S., Ryden, T., Månsson, W., Liedberg, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4213 · Cited by 310
Wu, X., Ye, Y., Kiemeney, L. A., Sulem, P., Rafnar, T., Matullo, G., Seminara, D., Yoshida, T., Saeki, N., Andrew, A. S., et al. (2009) · Nature Genetics · doi:10.1038/ng.421 · Cited by 287
Parekh, D. J., Messer, J., Fitzgerald, J., Ercole, B., & Svatek, R. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.09.077 · Cited by 284
Allory, Y., Beukers, W., Sagrera, A., Flández, M., Marqués, M., Márquez, M., van der Keur, K. A., Dyrskjot, L., Lurkin, I., Vermeij, M., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.052 · Cited by 284
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
Balbás-Martínez, C., Sagrera, A., Carrillo-de-Santa-Pau, E., Earl, J., Márquez, M., Vazquez, M., Lapi, E., Castro-Giner, F., Beltran, S., Bayés, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2799 · Cited by 273
Three differentiation states risk-stratify bladder cancer into distinct subtypes
Volkmer, J.-P., Sahoo, D., Chin, R. K., Ho, P. L., Tang, C., Kurtova, A. V., Willingham, S. B., Pazhanisamy, S. K., Contreras-Trujillo, H., Storm, T. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120605109 · Cited by 259
Self-citationBiomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non–Small-Cell Lung Cancer: A Review
Sacher, A. G., & Gandhi, L. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0639 · Cited by 255
Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
Platt, F. M., Hurst, C. D., Taylor, C. F., Gregory, W. M., Harnden, P., & Knowles, M. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0898 · Cited by 251
Self-citationDi̇vri̇k, R. T., Yildirim, Ü., Zorlu, F., & Özen, H. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)01002-5 · Cited by 250
Tyson, M. D., & Chang, S. S. (2016) · European Urology · doi:10.1016/j.eururo.2016.05.031 · Cited by 221
López-Knowles, E., Hernández, S., Malats, N., Kogevinas, M., Lloreta, J., Carrato, A., Tardón, A., Serra, C., Real, F. X., & EPICURO Study Group Investigators (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1182 · Cited by 218
Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting
Lerner, S. P., McConkey, D. J., Hoadley, K. A., Chan, K. S., Kim, W. Y., Radvanyi, F., Höglund, M., & Real, F. X. (2016) · Bladder Cancer · doi:10.3233/blc-150037 · Cited by 213
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
Sylvester, R. J., van der Meijden, A., Witjes, J. A., Jakse, G., Nonomura, N., Cheng, C., Torres, A., Watson, R., & Kurth, K. H. (2005) · Urology · doi:10.1016/j.urology.2005.06.135 · Cited by 211
Bruins, H. M., Veskimae, E., Hernandez, V., Imamura, M., Neuberger, M. M., Dahm, P., Stewart, F., Lam, T. B., N’Dow, J., van der Heijden, A. G., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.05.031 · Cited by 210
Frequent truncating mutations of STAG2 in bladder cancer
Solomon, D. A., Kim, J.-S., Bondaruk, J., Shariat, S. F., Wang, Z.-F., Elkahloun, A. G., Ozawa, T., Gerard, J., Zhuang, D., Zhang, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2800 · Cited by 208
Martin-Doyle, W., Leow, J. J., Orsola, A., Chang, S. L., & Bellmunt, J. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.6967 · Cited by 207
Reinert, T., Modin, C., Castano, F. M., Lamy, P., Wojdacz, T. K., Hansen, L. L., Wiuf, C., Borre, M., Dyrskjøt, L., & Ørntoft, T. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2659 · Cited by 207
Claudin-low bladder tumors are immune infiltrated and actively immune suppressed
Kardos, J., Chai, S., Mose, L. E., Selitsky, S. R., Krishnan, B., Saito, R., Iglesia, M. D., Milowsky, M. I., Parker, J. S., Kim, W. Y., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85902 · Cited by 207
Fritsche, H.-M., Burger, M., Svatek, R. S., Jeldres, C., Karakiewicz, P. I., Novara, G., Skinner, E., Denzinger, S., Fradet, Y., Isbarn, H., et al. (2010) · European Urology · doi:10.1016/j.eururo.2009.09.024 · Cited by 201
Self-citationClonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies
Hafner, C., Knuechel, R., Stoehr, R., & Hartmann, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10544 · Cited by 200
Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma
Shin, K., Lim, A., Odegaard, J. I., Honeycutt, J. D., Kawano, S., Hsieh, M. H., & Beachy, P. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2956 · Cited by 199
Bladder cancers arise from distinct urothelial sub-populations
Van Batavia, J., Yamany, T., Molotkov, A., Dan, H., Mansukhani, M., Batourina, E., Schneider, K., Oyon, D., Dunlop, M., Wu, X.-R., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3038 · Cited by 199
Karl, A., Buchner, A., Becker, A., Staehler, M., Seitz, M., Khoder, W., Schneevoigt, B., Weninger, E., Rittler, P., Grimm, T., et al. (2014) · Journal of Urology · doi:10.1016/j.juro.2013.08.019 · Cited by 194
Frequent FGFR3 mutations in urothelial papilloma
van Rhijn, B. W. G., Montironi, R., Zwarthoff, E. C., Jöbsis, A. C., & van der Kwast, T. H. (2002) · The Journal of Pathology · doi:10.1002/path.1202 · Cited by 189
Urakami, S., Shiina, H., Enokida, H., Kawakami, T., Tokizane, T., Ogishima, T., Tanaka, Y., Li, L.-C., Ribeiro-Filho, L. A., Terashima, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1344 · Cited by 189
Wu, A. W., Kharrazi, H., Boulware, L. E., & Snyder, C. F. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.04.005 · Cited by 188
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
Kiemeney, L. A., Sulem, P., Besenbacher, S., Vermeulen, S. H., Sigurdsson, A., Thorleifsson, G., Gudbjartsson, D. F., Stacey, S. N., Gudmundsson, J., Zanon, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.558 · Cited by 188
Self-citationA new tumor suppressor role for the Notch pathway in bladder cancer
Rampias, T., Vgenopoulou, P., Avgeris, M., Polyzos, A., Stravodimos, K., Valavanis, C., Scorilas, A., & Klinakis, A. (2014) · Nature Medicine · doi:10.1038/nm.3678 · Cited by 184
Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers
Cairns, P., Evron, E., Okami, K., Halachmi, N., Esteller, M., Herman, J. G., Bose, S., Wang, S. I., Parsons, R., & Sidransky, D. (1998) · Oncogene · doi:10.1038/sj.onc.1201855 · Cited by 180
Toward a Molecular Pathologic Classification of Urothelial Carcinoma
Sjödahl, G., Lövgren, K., Lauss, M., Patschan, O., Gudjonsson, S., Chebil, G., Aine, M., Eriksson, P., Månsson, W., Lindgren, D., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.05.013 · Cited by 180
Wolff, E. M., Chihara, Y., Pan, F., Weisenberger, D. J., Siegmund, K. D., Sugano, K., Kawashima, K., Laird, P. W., Jones, P. A., & Liang, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1335 · Cited by 180
Muscle‐invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base
Smith, A. B., Deal, A. M., Woods, M. E., Wallen, E. M., Pruthi, R. S., Chen, R. C., Milowsky, M. I., & Nielsen, M. E. (2014) · BJU International · doi:10.1111/bju.12601 · Cited by 171
Self-citationOccupational and Environmental Exposures and Cancers in Developing Countries
Hashim, D., & Boffetta, P. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2014.10.002 · Cited by 171
Simon, R., Richter, J., Wagner, U. A., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R. E., Alund, G., Knönagel, H., et al. (2001) · PubMed · Cited by 162
Perlis, N., Zlotta, A. R., Beyene, J., Finelli, A., Fleshner, N. E., & Kulkarni, G. S. (2013) · European Urology · doi:10.1016/j.eururo.2013.06.009 · Cited by 161
May, M., Brookman-Amissah, S., Roigas, J., Hartmann, A., Störkel, S., Kristiansen, G., Gilfrich, C., Borchardt, R., Hoschke, B., Kaufmann, O., et al. (2010) · European Urology · doi:10.1016/j.eururo.2009.03.052 · Cited by 160
Ross, J. S., Wang, K., Gay, L. M., Al-Rohil, R. N., Nazeer, T., Sheehan, C. E., Jennings, T. A., Otto, G. A., Donahue, A. L., He, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1992 · Cited by 158
Hormonal and Reproductive Factors and the Risk of Bladder Cancer in Women
McGrath, M., Michaud, D. S., & De Vivo, I. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj028 · Cited by 158
Amplification pattern of 12q13–q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer
Simon, R., Struckmann, K., Schraml, P., Wagner, U., Forster, T., Moch, H., Fijan, A., Bruderer, J., Wilber, K., Mihatsch, M. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205304 · Cited by 157
Hurst, C. D., Platt, F. M., & Knowles, M. A. (2013) · European Urology · doi:10.1016/j.eururo.2013.08.057 · Cited by 157
Self-citationPalou, J., Rodríguez-Rubio, F., Huguet, J., et al. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000169424.79702.6d · Cited by 155
Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer
Nordentoft, I., Lamy, P., Birkenkamp‐Demtröder, K., Shumansky, K., Vang, S., Hornshøj, H., Juul, M., Villesen, P., Hedegaard, J., Roth, A. J. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.038 · Cited by 151
Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise
Kim, J., Akbani, R., Creighton, C. J., Lerner, S. P., Weinstein, J. N., Getz, G. A., & Kwiatkowski, D. J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1215 · Cited by 140
Immunotherapy for the Treatment of Urothelial Carcinoma
Donin, N. M., Lenis, A. T., Holden, S., Drakaki, A., Pantuck, A. J., Belldegrun, A. S., & Chamie, K. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.02.3005 · Cited by 137
Marsit, C. J., Karagas, M. R., Andrew, A. S., Liu, M., Danaee, H., Schned, A. R., Nelson, H. H., & Kelsey, K. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0267 · Cited by 134
Lindgren, D., Liedberg, F., Andersson, A., Chebil, G., Guðjónsson, S., Borg, Å., Månsson, W., Fioretos, T., & Höglund, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209249 · Cited by 134
Gilbert, S. M., Dunn, R. L., Hollenbeck, B. K., Montie, J. E., Lee, C. T., Wood, D. P., & Wei, J. T. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.01.013 · Cited by 133
Obermann, E. C., Junker, K., Stoehr, R., Dietmaier, W., Zaak, D., Schubert, J., Hofstaedter, F., Knuechel, R., & Hartmann, A. (2002) · The Journal of Pathology · doi:10.1002/path.1259 · Cited by 129
Mahdavifar, N., Ghoncheh, M., Pakzad, R., Momenimovahed, Z., & Salehiniya, H. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.1.381 · Cited by 129
The proportion of cancer attributable to occupational exposures
Purdue, M. P., Hutchings, S. J., Rushton, L., & Silverman, D. T. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.11.009 · Cited by 127
New Therapeutic Challenges in Advanced Bladder Cancer
Joaquim Bellmunt, B., & Petrylak, D. P. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.08.007 · Cited by 127
van der Aa, M. N. M., Steyerberg, E. W., Bangma, C. H., et al. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.08.150 · Cited by 126
Rebouissou, S., Hérault, A., Letouzé, É., Neuzillet, Y., Laplanche, A., Ofualuka, K., Maillé, P., Leroy, K., Riou, A., Lepage, M., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4017 · Cited by 122
Sjödahl, G., Lauss, M., Guðjónsson, S., Liedberg, F., Halldén, C., Chebil, G., Månsson, W., Höglund, M., & Lindgren, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018583 · Cited by 119
Ethnic Differences in Bladder Cancer Survival
Yee, D. S., Ishill, N. M., Lowrance, W. T., Herr, H. W., & Elkin, E. B. (2011) · Urology · doi:10.1016/j.urology.2011.02.042 · Cited by 117
Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis
Mo, L., Zheng, X., Huang, H.-Y., Shapiro, E., Lepor, H., Cordon‐Cardo, C., Sun, T., & Wu, X. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30062 · Cited by 117
Androgen deprivation therapy prevents bladder cancer recurrence
Izumi, K., Taguri, M., Miyamoto, H., Hara, Y., Kishida, T., Chiba, K., Murai, T., Hirai, K., Suzuki, K., Fujinami, K., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2851 · Cited by 112
Biological determinants of bladder cancer gene expression subtypes
Aine, M., Eriksson, P., Liedberg, F., Sjödahl, G., & Höglund, M. (2015) · Scientific Reports · doi:10.1038/srep10957 · Cited by 112
Meta‐analysis: does lidocaine gel before flexible cystoscopy provide pain relief?
Aaronson, D. S., Walsh, T. J., Smith, J. F., Davies, B. J., Hsieh, M. H., & Konety, B. R. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08417.x · Cited by 112
Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
Hurst, C. D., Platt, F. M., Taylor, C., & Knowles, M. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1807 · Cited by 112
Self-citationAskham, J. M., Platt, F. M., Chambers, P. A., Snowden, H. H., Taylor, C. F., & Knowles, M. A. (2009) · Oncogene · doi:10.1038/onc.2009.315 · Cited by 110
Self-citationTakayama, K., Kaneshiro, K., Tsutsumi, S., Horie‐Inoue, K., Ikeda, K., Urano, T., Ijichi, N., Ouchi, Y., Shirahige, K., Aburatani, H., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210229 · Cited by 110
di Martino, E., L’Hôte, C., Kennedy, W., Tomlinson, D. C., & Knowles, M. A. (2009) · Oncogene · doi:10.1038/onc.2009.280 · Cited by 108
Self-citationKnoedler, J., Boorjian, S. A., Kim, S. P., Weight, C., Thapa, P. B., Tarrell, R. F., Cheville, J. C., & Frank, I. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.06.029 · Cited by 108
FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms
Tomlinson, D. C., Baxter, E. W., Loadman, P. M., Hull, M. A., & Knowles, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038972 · Cited by 96
Self-citationOncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 Amplification
Habuchi, T., Kinoshita, H., Yamada, H., Kakehi, Y., Ogawa, O., Wu, W., Takahashi, R., Sugiyama, T., & Yoshida, O. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.17.1331 · Cited by 96
Blazeby, J. M., Hall, E., Aaronson, N. K., Lloyd, L., Waters, R., Kelly, J. D., & Fayers, P. M. (2014) · European Urology · doi:10.1016/j.eururo.2014.02.034 · Cited by 96
Casey, R. G., Catto, J. W. F., Cheng, L., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.10.040 · Cited by 95
Lamy, P., Nordentoft, I., Birkenkamp‐Demtröder, K., Thomsen, M. B. H., Villesen, P., Vang, S., Hedegaard, J., Borre, M., Jensen, J. B., Høyer, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0436 · Cited by 93
Daneshmand, S., Schuckman, A. K., Bochner, B. H., Cookson, M. S., Downs, T. M., Gomella, L. G., Grossman, H. B., Kamat, A. M., Konety, B. R., Lee, C. T., et al. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.245 · Cited by 89
Vallot, C., Stransky, N., Bernard‐Pierrot, I., Hérault, A., Zucman‐Rossi, J., Chapeaublanc, E., Vordos, D., Laplanche, A., Benhamou, S., Lebrét, T., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq470 · Cited by 88
p53 and retinoblastoma pathways in bladder cancer
Mitra, A. P., Birkhahn, M., & Côté, R. J. (2007) · World Journal of Urology · doi:10.1007/s00345-007-0197-0 · Cited by 84
Liang Cheng, C., Gu, J., Ulbright, T. M., MacLennan, G. T., Sweeney, C. J., Zhang, S., Sanchez, K., Koch, M. O., & Eble, J. N. (2001) · Cancer · doi:10.1002/cncr.10151 · Cited by 84
Majewski, T., Lee, S., Jeong, J., Yoon, D. S., Kram, A., Kim, M., Tuziak, T., Bondaruk, J. E., Lee, S., Park, W. S., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.27 · Cited by 81
Yuh, B. E., Ruel, N. H., Wilson, T. G., Vogelzang, N. J., & Pal, S. K. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.10.120 · Cited by 81
Yates, D. R., Brausi, M. A., Catto, J. W. F., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.08.055 · Cited by 81
Nonurothelial Bladder Cancer and Rare Variant Histologies
Willis, D. L., & Kamat, A. M. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.10.011 · Cited by 77
Genetic Susceptibility to Distinct Bladder Cancer Subphenotypes
Guey, L. T., García‐Closas, M., Murta‐Nascimento, C., Lloreta, J., Palència, L., Kogevinas, M., Rothman, N., Vellalta, G., Calle, M. L., Marenne, G., et al. (2009) · European Urology · doi:10.1016/j.eururo.2009.08.001 · Cited by 76
Cantiello, F., Cicione, A. M., Salonia, A., Riccardo Autorino, B., Nunzio, C. D., Briganti, A., Gandaglia, G., Dell’Oglio, P., Capogrosso, P., & Damiano, R. (2014) · International Journal of Urology · doi:10.1111/iju.12644 · Cited by 74
Tomlinson, D. C., L’Hôte, C., Kennedy, W., Pitt, E., & Knowles, M. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1718 · Cited by 74
Self-citationMolecular analysis ofPTEN andMXI1 in primary bladder carcinoma
Wang, D. S., Rieger‐Christ, K., Latini, J. M., Moinzadeh, A., Stoffel, J. T., Pezza, J. A., Saini, K. S., Libertino, J. A., & Summerhayes, I. C. (2000) · International Journal of Cancer · Cited by 72
Tomlinson, D. C., & Knowles, M. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100354 · Cited by 70
Self-citationAnderson, C. B., Feurer, I. D., Large, M. C., Steinberg, G. D., Barocas, D. A., Cookson, M. S., & Penson, D. F. (2012) · Urology · doi:10.1016/j.urology.2012.01.090 · Cited by 69
Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1
Nakanishi, Y., Akiyama, N., Tsukaguchi, T., Fujii, T., Satoh, Y., Ishii, N., & Aoki, M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0927-t · Cited by 68
Godoy, G., Gakis, G., Smith, C. S., & Fahmy, O. (2016) · Bladder Cancer · doi:10.3233/blc-160052 · Cited by 67
Daugherty, S. E., James V. Lacey, Pfeiffer, R. M., Park, Y., Hoover, R. N., & Silverman, D. T. (2013) · International Journal of Cancer · doi:10.1002/ijc.28022 · Cited by 63
Pathological stage review is indicated in primary pT1 bladder cancer
van Rhijn, B. W. G., van der Kwast, T., Kakiashvili, D., Fleshner, N. E., van der Aa, M. N. M., Alkhateeb, S., Bangma, C. H., Jewett, M. A. S., & Zlotta, A. R. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.09100.x · Cited by 61
Hypermethylation in bladder cancer: biological pathways and translational applications
Sänchez‐Carbayo, M. (2012) · Tumor Biology · doi:10.1007/s13277-011-0310-2 · Cited by 59
Gao, J. X., Huang, H. Y., Pak, J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207169 · Cited by 59
p53 mutations in urinary bladder cancer
Berggren, P., Steineck, G., Adolfsson, J., Hansson, J., JANSSON, O. T., Larsson, P., Sandstedt, B., Wijkström, H., & Hemminki, K. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1823 · Cited by 58
Danna, B. J., Metcalfe, M., Wood, E. L., & Shah, J. B. (2016) · Bladder Cancer · doi:10.3233/blc-160057 · Cited by 57
On Molecular Classification of Bladder Cancer: Out of One, Many
Aine, M., Eriksson, P., Liedberg, F., Höglund, M., & Sjödahl, G. (2015) · European Urology · doi:10.1016/j.eururo.2015.07.021 · Cited by 55
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia
Lee, S., Jeong, J., Majewski, T., Scherer, S. E., Kim, M.-S., Tuziak, T., Tang, K. S., Baggerly, K., Grossman, H. B., Zhou, J.-H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701771104 · Cited by 52
Kavalieris, L., O’Sullivan, P. J., Suttie, J. M., Pownall, B. K., Gilling, P., Chemasle, C., & Darling, D. (2015) · BMC Urology · doi:10.1186/s12894-015-0018-5 · Cited by 51
Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies
Pelucchi, C., & Vecchia, C. L. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32830c8d44 · Cited by 48
Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma
Aine, M., Sjödahl, G., Eriksson, P., Veerla, S., Lindgren, D., Ringnér, M., & Höglund, M. (2015) · Genome Medicine · doi:10.1186/s13073-015-0144-4 · Cited by 44
Lerner, S. P., Bajorin, D. F., Dinney, C. P., Efstathiou, J. A., Groshen, S. G., Hahn, N. M., Hansel, D. E., Kwiatkowski, D. J., O’Donnell, M. A., Rosenberg, J. E., et al. (2016) · Bladder Cancer · doi:10.3233/blc-160053 · Cited by 43
Self-citationDudziec, E., Gogol‐Döring, A., Cookson, V. J., Chen, W., & Catto, J. W. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032750 · Cited by 37
Mapping and Genome Sequence Analysis of Chromosome 5 Regions Involved in Bladder Cancer Progression
Kram, A., Li, L., Zhang, R. D., Yoon, D. S., Ro, J. Y., Johnston, D. A., Grossman, H. B., Scherer, S. E., & Czerniak, B. A. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780315 · Cited by 34
Kim, M. S., Jeong, J., Majewski, T., Kram, A., Yoon, D. S., Zhang, R.-D., Li, J.-Z., Ptaszyński, K., Kuang, T. C., Zhou, J.-H., et al. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700378 · Cited by 22
The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder
Sfakianos, J. P., Gellert, L. L., Maschino, A. C., Gotto, G. T., Kim, P. H., Al‐Ahmadie, H. A., & Bochner, B. H. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.02.003 · Cited by 19
An, Y., Li, H., Wang, K. J., Liu, X.-H., Qiu, M., Liao, Y., Huang, J., & Wang, X. S. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.14.17 · Cited by 8
Cheng, S., Andrew, A. S., Andrews, P. C., & Moore, J. H. (2016) · BioData Mining · doi:10.1186/s13040-016-0119-z · Cited by 8
Cited by
Dyrskjøt, L., Hansel, D. E., Efstathiou, J. A., Knowles, M. A., Galsky, M. D., Teoh, J., & Theodorescu, D. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00468-9 · Cited by 544
Self-citationAdvances in diagnosis and treatment of bladder cancer
Lopez-Beltran, A., Cookson, M. S., Guercio, B. J., & Cheng, L. (2024) · BMJ · doi:10.1136/bmj-2023-076743 · Cited by 496
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Pettenati, C., & Ingersoll, M. A. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0055-4 · Cited by 457
Fibroblast growth factor receptors as treatment targets in clinical oncology
Katoh, M. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0115-y · Cited by 352
Goulet, C. R., Champagne, A., Bernard, G., Vandal, D., Chabaud, S., Pouliot, F., & Bolduc, S. (2019) · BMC Cancer · doi:10.1186/s12885-019-5353-6 · Cited by 322
Metadata
- Authors
- Sanli, O., Dobruch, J., Knowles, M. A., Burger, M., Alemozaffar, M., Nielsen, M. E., & Lotan, Y.
- Venue
- Nature Reviews Disease Primers
- Published
- 2017-04-13
- Volume
- 3
- Issue
- 1
- Pages
- 17022-17022
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211053712
- Cited by
- 814
- References
- 164
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.